A CDSCO neurological medical device license is mandatory under India's Medical Devices Rules, 2017 for any manufacturer or importer of notified neurological devices — including EEG machines, electromyographs, deep brain stimulation systems, cerebrospinal fluid shunt programmers, spinal cord stimulators, and vagus nerve stimulation systems. Neurological devices span Class A through Class D. Manufacturing Class A and B devices requires a Form MD5 license from the State Licensing Authority (fee: Rs. 5,000 plus Rs. 500 per device). Manufacturing Class C and D devices requires a Form MD9 license from CDSCO Central (fee: Rs. 50,000 plus Rs. 1,000 per device). Importing any class requires a Form MD15 import license from CDSCO. All three license types are valid indefinitely, subject to a retention fee paid every 5 years — non-payment results in automatic cancellation. Applications are submitted through the CDSCO SUGAM portal (cdscoonline.gov.in). ISO 13485 certification and a Device Master File are mandatory for all manufacturing license applications.
Neurology is the medical discipline concerned with the diagnosis and treatment of disorders of the nervous system — the brain, spinal cord, peripheral nerves, and neuromuscular junction. The conditions it encompasses range from highly prevalent chronic conditions such as epilepsy, Parkinson's disease, and neuropathic pain to acute and life-threatening events such as stroke and traumatic brain injury. Neurological medical devices serve this broad clinical landscape, encompassing diagnostic instruments that capture neural electrical activity, monitoring systems, cerebrospinal fluid management devices, and advanced implantable neuromodulation systems that deliver electrical stimulation to modify abnormal neural activity.
India carries one of the world's largest absolute burdens of neurological disease, yet access to specialist neurological care and to the advanced neurodiagnostic and neuromodulation devices that underpin it remains deeply constrained — particularly outside major metropolitan centres. This gap between the scale of need and the availability of devices and trained specialists defines the regulatory and commercial context for CDSCO's neurological device framework. CDSCO's licensing requirements exist precisely because, for devices that interact directly with the brain, spinal cord, or peripheral nervous system, the consequences of device failure or substandard quality can be severe and irreversible. This guide sets out what manufacturers and importers of neurological medical devices need to know to obtain and maintain CDSCO licensing in India.
📑 Quick Navigation
- Demand for Neurological Medical Devices in India
- CDSCO Regulations for Neurological Devices: Mandatory Compliance
- CDSCO Classification: Neurological Devices by Class
- Mandatory Documents for CDSCO Neurological Device License
- Three CDSCO License Types: MD5, MD9, MD15
- 5-Step Application Process Through CDSCO SUGAM
- License Validity and Retention Fee Requirements
- 5 Benefits of CDSCO Licensing for Neurological Device Manufacturers
- How Rego Services Supports Your CDSCO Application
- Frequently Asked Questions
Demand for Neurological Medical Devices in India
India's neurological disease burden is substantial and structurally growing. Epilepsy affects an estimated 10–12 million people in India, representing nearly 17% of the global epilepsy burden. Parkinson's disease incidence is rising alongside an ageing population. Stroke is a leading cause of disability, with India estimated to account for approximately one-fifth of the global stroke burden. Neuropathic pain conditions are common sequelae of diabetes — itself a major and expanding public health challenge — and traumatic brain injury rates remain high against the backdrop of India's road traffic accident burden.
Despite the scale of this disease burden, access to neurological care and to advanced neurological devices remains severely constrained. Neurologists are concentrated in urban tertiary centres, and the availability of neurodiagnostic equipment such as EEG machines and electromyographs — the foundational tools of outpatient neurology — is inadequate relative to need, particularly in secondary towns and rural areas. Advanced neuromodulation therapies such as deep brain stimulation for Parkinson's disease and drug-resistant epilepsy, and spinal cord stimulation for refractory neuropathic pain, are available only at a small number of specialist centres, far fewer than the patient population that could benefit from them warrants.
Several factors are accelerating market growth beyond the baseline disease burden. Rising neurological awareness — driven by patient advocacy, medical education campaigns, and increased media coverage of conditions such as Parkinson's disease and epilepsy — is generating earlier and more frequent healthcare-seeking behaviour, increasing demand for diagnostic neurological devices. Government investment in neurology infrastructure and expanding health insurance coverage are gradually expanding the universe of patients who can access advanced neurological care. Innovation in neuromodulation technology — including minimally invasive deep brain stimulation approaches and next-generation closed-loop stimulation systems — is expanding both the clinical indications and the patient populations for which implantable neuromodulation therapy is appropriate. For device manufacturers and importers willing to engage seriously with CDSCO's licensing framework, this combination of underserved baseline demand and structural growth drivers represents a commercially significant opportunity.
CDSCO Regulations for Neurological Devices: Mandatory Compliance
The regulatory imperative for neurological medical devices in India derives directly from the clinical stakes involved. Many neurological devices — particularly Class C and D devices such as deep brain stimulation systems, cerebrospinal fluid shunt programmers, intracranial vascular stents, and spinal cord stimulators — are implanted directly into or in close proximity to the central nervous system. Device failure, material degradation, or contamination in this context carries a risk of acute neurological injury, stroke, infection, or death. Even for non-implantable Class C diagnostic devices such as cerebrospinal fluid manometers, inaccuracy or malfunction can directly compromise clinical decision-making for patients whose conditions require precise monitoring.
CDSCO's regulatory framework for neurological devices under the Medical Devices Rules, 2017 reflects this risk profile. The MDR 2017 requires that all manufacturers and importers of notified neurological medical devices obtain the applicable CDSCO license before any manufacturing or import activity begins. This is not a procedural formality — it is a legally enforceable requirement whose breach exposes manufacturers, importers, and their representatives to enforcement action under the Drugs and Cosmetics Act and the Medical Devices Rules.
CDSCO Classification: Neurological Devices by Class
The Medical Devices Rules, 2017 classify all notified medical devices into four risk-based classes — A (lowest risk) through D (highest risk) — to calibrate regulatory requirements proportionately to patient risk. The applicable license type, licensing authority, and fee structure all depend on the class of the specific neurological device being licensed. The following sets out real device examples across all four classes within the CDSCO neurological device category.
- Analytical non-scalp cutaneous electrode
- Analytical non-scalp cutaneous lead
- Back / leg / chest dynamometer
- Skull plate anvil
- Skull punch
- Skull plate screwdriver
- Tuning fork
- Ultrasonic scanner calibration test block
- Analgesic PENS system
- Analgesic TENS system
- Analytical scalp electrode
- Analytical scalp lead
- Arthritis TENS system
- Electroencephalographic (EEG) simulator
- Electromyograph (EMG)
- Electronystagmograph
- Autonomic neuropathy heart rate meter
- Behavioural therapy electrical stimulation system
- Brain injury adjunctive interpretive EEG assessment aid
- Cerebrospinal fluid (CSF) manometer
- CSF shunt valve programmer
- Deep brain electrical stimulation system lead
- Depth electrode
- Diagnostic peripheral nerve electrical stimulation system
- Analgesic spinal cord electrical stimulation system
- Aneurysm clip
- Antiseizure / psychiatric-therapy vagus nerve stimulation system
- Atrial cerebrospinal fluid catheter
- Bare-metal intracranial vascular stent
- Bladder / bowel-evacuation implantable electrical stimulation system
- Brain-responsive electrical stimulation system
- Cardiac-therapy vagus nerve electrical stimulation system
- Cerebral perfusion catheter
- Coma-arousal vagus nerve electrical stimulation system
- Implantable lumbar neuromuscular electrical stimulation system pulse generator
- Implantable pulse generator mesh bag, bioabsorbable
- Implantable sleep apnoea treatment system
Mandatory Documents for CDSCO Neurological Device License Application
A complete and well-prepared document set is the single largest determinant of how smoothly and quickly a CDSCO neurological device license application moves through review. Gaps, inconsistencies, or insufficient technical detail — particularly in the Device Master File for Class C and D implantable devices — are the most common source of reviewer queries and application delays in this device category.
- Organisation identity proof — Certificate of Incorporation, Memorandum and Articles of Association, GST registration certificate, and other applicable documents establishing the legal identity and standing of the applicant company.
- Sale Deed or Rent Deed of the premises — Valid documentary evidence of the applicant's right to occupy the declared manufacturing facility or registered premises.
- Building Layout with dimension — An accurate, dimensioned floor plan of the manufacturing facility showing production areas, clean-room or controlled environment zones (relevant for implantable neurological devices), quality control laboratory, storage areas, and personnel facilities, prepared in accordance with CDSCO requirements.
- Plant Master File (PMF) — A comprehensive document describing the manufacturing facility's location, layout, process flows, equipment, calibration and maintenance programme, environmental monitoring (particularly for sterile implantable device manufacturing), and quality management infrastructure. For Class C and D neurological implants, the PMF must demonstrate GMP compliance to the standard CDSCO expects for implantable device manufacturing.
- Device Master File (DMF) — A comprehensive technical dossier covering the neurological device's design, intended use, manufacturing process, risk management file (prepared to ISO 14971 standard), biocompatibility testing data (prepared to ISO 10993), electrical safety and EMC testing data, performance and accuracy testing data, labelling and Instructions for Use, and post-market surveillance plan. For implantable neurological devices — spinal cord stimulators, vagus nerve stimulation systems, intracranial stents, and deep brain stimulation leads — the risk management file and biocompatibility data are the elements most closely scrutinised by CDSCO reviewers.
- Documents for the team of qualified staff — Curriculum vitae, qualifications, and appointment letters for personnel responsible for manufacturing and testing the neurological devices, demonstrating that CDSCO's minimum qualification requirements are satisfied.
- Environmental regulation compliance documents — Applicable Pollution Control Board clearances and waste disposal documentation, particularly relevant where manufacturing generates regulated waste streams.
- Certificate of Analysis of 3 consecutive batches — Documentary proof that the manufacturing process consistently produces neurological devices meeting declared specifications. For first-time manufacturers, these batches must be produced under a valid CDSCO MD13 test license.
- ISO 13485 Certificate — A current, in-scope certificate from an IAF-accredited certification body covering the manufacturing activities relevant to the neurological device being licensed. This is a mandatory hard requirement for both MD5 and MD9 applications.
- Test License, if required for testing the device — Where production batches were manufactured under an MD13 test license prior to the permanent license application, a copy of that test license must be included to contextualise the batch data submitted.
For Class C and D neurological devices — deep brain stimulation leads, spinal cord stimulators, vagus nerve stimulation systems, intracranial vascular stents, and cerebral perfusion catheters — the risk management file and biocompatibility testing data within the Device Master File receive particularly close CDSCO scrutiny. These devices interface directly and continuously with neural tissue or the central nervous system, and failures carry the potential for acute, serious, and irreversible neurological harm. Manufacturers should ensure risk management documentation is prepared to ISO 14971 and that biocompatibility data covers all relevant ISO 10993 endpoints for the specific material-tissue contact involved.
CDSCO Medical Device Test License (MD13 / MD17) India 2026 — Complete Guide
If you are a first-time manufacturer of neurological medical devices and need to produce the three consecutive batch Certificate of Analysis required for your MD5 or MD9 application, an MD13 test license is the legally required first step before production can begin. This guide covers the complete test license process — mandatory documents, the 5-step SUGAM application, and validity rules.
Three CDSCO License Types: MD5, MD9, MD15
Three distinct CDSCO license types apply to neurological medical devices, determined by whether the applicant is manufacturing or importing, and — for manufacturers — the risk class of the specific device being licensed.
Manufacturing Class A and B neurological devices — such as tuning forks, non-scalp electrodes, and TENS systems — requires an MD5 license with a fee of Rs. 5,000 plus Rs. 500 for each distinct device, obtained from the State Licensing Authority. Manufacturing Class C and D neurological devices — such as deep brain stimulation leads, CSF shunt valve programmers, spinal cord stimulators, and vagus nerve stimulation systems — requires an MD9 license with a fee of Rs. 50,000 plus Rs. 1,000 for each distinct device, obtained from the Central Licensing Authority at CDSCO. Importing neurological devices of any class into India requires an MD15 import license from CDSCO Central.
5-Step Application Process Through CDSCO SUGAM
The CDSCO neurological medical device license application follows a defined five-step process, filed entirely through the CDSCO SUGAM online portal at cdscoonline.gov.in.
Compile all necessary documents required for the license application — organisation identity proof, premises documents, building layout, Plant Master File, Device Master File, qualified personnel documentation, environmental compliance documents, Certificate of Analysis for three consecutive batches, ISO 13485 certificate, and test license if applicable. For Class C and D neurological implants, the Device Master File must include a complete risk management file prepared to ISO 14971 and biocompatibility data prepared to ISO 10993. All documents must be internally reviewed for completeness and consistency before submission.
File the application online on CDSCO's official SUGAM portal at cdscoonline.gov.in, selecting the applicable license form — MD5, MD9, or MD15 — based on the confirmed device classification. Carefully attach all necessary supporting documents in the formats and sizes specified by the portal, and pay the applicable government fee to formally submit the application. Procedural errors at this stage — incorrect form selection, missing attachments, or fee underpayment — cause avoidable delays.
CDSCO may raise written queries on the submitted application and documents through the SUGAM portal. For Class C and D neurological device applications, queries most commonly relate to the Device Master File's risk management documentation, biocompatibility testing scope, and electrical safety data. These queries must be addressed promptly and accurately — delayed or incomplete responses are the single most common cause of extended application timelines for neurological device applications.
For manufacturing license applications (MD5 and MD9), CDSCO regulatory officials may visit the medical device manufacturing facility for inspection, to verify compliance with the manufacturing processes, quality systems, environmental controls, and personnel qualifications declared in the Plant Master File and Device Master File. For implantable Class C and D neurological device manufacturers, inspection readiness — including demonstrable GMP implementation — is particularly important.
Once all criteria are satisfied — queries fully resolved and any inspection findings cleared — CDSCO grants the applicable neurological medical device license: Form MD5, MD9, or MD15, issued through the SUGAM portal. The license is granted in the applicant's name and is specific to the device(s) and manufacturing premises declared in the application.
License Validity and Retention Fee Requirements
The CDSCO neurological medical device license is valid indefinitely from the date of grant. However, the license retention fee must be paid every 5 years — failure to do so results in automatic cancellation of the license, requiring a completely fresh application to resume manufacturing or import activity.
| Parameter | MD5 — Class A/B Manufacture | MD9 — Class C/D Manufacture | MD15 — Import All Classes |
|---|---|---|---|
| Validity | Indefinite | Indefinite | Indefinite |
| Retention fee cycle | Every 5 years | Every 5 years | Every 5 years |
| Effect of non-payment | Automatic cancellation | Automatic cancellation | Automatic cancellation |
| Issuing authority | State Licensing Authority | CDSCO (Central) | CDSCO (Central) |
| Initial license fee | Rs. 5,000 + Rs. 500/device | Rs. 50,000 + Rs. 1,000/device | Class-dependent |
5 Benefits of CDSCO Licensing for Neurological Device Manufacturers
A valid CDSCO license is the legal prerequisite for placing neurological devices on the Indian market — a market defined by one of the world's largest neurological disease burdens and a persistent, structural shortfall in the availability of neurodiagnostic and neuromodulation technology. Obtaining the license converts this unmet clinical need into a legally accessible commercial channel, positioning the device manufacturer or importer to serve a market segment where demand materially exceeds current supply.
Neurologists and neurosurgeons prescribing or implanting devices for conditions such as Parkinson's disease, drug-resistant epilepsy, and refractory neuropathic pain apply rigorous scrutiny to device quality and regulatory status. CDSCO licensing — backed by ISO 13485 certification, a comprehensive Device Master File, and biocompatibility testing data — signals that a manufacturer's devices meet a verified standard of safety and performance, supporting the trust-based clinical relationships that are essential for commercial success in this specialty.
Neurological devices imported without a valid CDSCO MD15 import license face customs detention and potential seizure. For hospitals and neurology centres with scheduled neuromodulation implant procedures or EEG diagnostic programmes, a customs delay — even of a few days — can disrupt patient scheduling and treatment continuity. A valid MD15 license ensures that imported neurological devices clear customs without interruption, supporting reliable supply to clinical partners.
India's government has invested in programmes to expand neurological care access, including initiatives targeting epilepsy management and stroke care infrastructure, as part of the broader National Programme for Non-Communicable Diseases. CDSCO licensing is a mandatory eligibility condition for device supply to government health programmes and empanelled hospitals. Manufacturers and importers with valid licenses gain access to a public health procurement channel that operates at significant scale and offers stable, long-term demand.
With neurological disease incidence in India tracking ageing demographics, rising diabetes prevalence, and continued high rates of traumatic brain and spinal cord injury, the underlying demand for neurological medical devices is structurally durable. A CDSCO license with indefinite validity provides the long-term regulatory foundation from which manufacturers and importers can incrementally expand their neurological device portfolio — adding new neuromodulation indications, diagnostic devices, and monitoring systems — as the market and their clinical relationships mature.
CDSCO General Hospital Medical Device License India 2026 — Complete Guide
Neurological device manufacturers whose portfolio also includes general hospital equipment — patient monitoring systems, infusion devices, or surgical instruments used in neurology and neurosurgery settings — should review the CDSCO licensing requirements for the general hospital device category, which may apply alongside neurological device-specific licensing requirements depending on the devices in scope.
How Rego Services Supports Your CDSCO Application
Securing the CDSCO neurological medical device license is a substantive regulatory undertaking. It requires precise device classification, a thorough understanding of CDSCO's documentation requirements across all four device classes, and — for Class C and D implantable devices — the preparation of technically demanding risk management and biocompatibility documentation that is routinely the subject of CDSCO reviewer scrutiny. Rego Services Private Limited provides end-to-end support for CDSCO neurological medical device license applications across all device classes and license types.
- Device classification confirmation and licensing strategy — We confirm the CDSCO class of your neurological device, identify the applicable license type (MD5, MD9, or MD15), and assess whether an MD13 test license is required before the permanent license application can be filed.
- ISO 13485 certification support — Where ISO 13485 certification is not yet in place, we support the full certification process on a timeline coordinated with the CDSCO license application to avoid unnecessary delays.
- Device Master File preparation — We prepare comprehensive Device Master Files for neurological devices, with particular emphasis on the risk management file (ISO 14971), biocompatibility testing data (ISO 10993), and electrical safety and EMC documentation that CDSCO scrutinises most closely for implantable and active neurological devices.
- Plant Master File preparation — We prepare Plant Master Files that accurately and comprehensively describe the manufacturing facility — including controlled environment and GMP compliance evidence — to the standard CDSCO reviewers and inspectors expect for Class C and D neurological device manufacturing.
- Batch production and Certificate of Analysis support — We support the planning and documentation of the three consecutive batch production runs required for MD5 and MD9 applications, including coordination with test license requirements for first-time manufacturers.
- SUGAM portal submission management — We manage the complete online application process — form selection, document upload, fee payment, and formal submission — to eliminate procedural errors and submission delays.
- Query response and inspection preparation — We draft responses to CDSCO reviewer queries and prepare manufacturing facilities for CDSCO inspection, drawing on our direct experience of the query patterns and inspection focus areas most commonly encountered in neurological device applications.
- Post-grant compliance and retention fee management — We maintain retention fee compliance calendars and provide ongoing CDSCO compliance support after license grant, ensuring you maintain active license status and avoid the automatic cancellation risk associated with missed retention fee deadlines.
Frequently Asked Questions
Is a separate CDSCO license required for each individual neurological device model, or can multiple models be covered on one license?
A single MD5 or MD9 manufacturing license can cover multiple distinct neurological device models manufactured at the same facility, provided each distinct device is declared in the application and the additional per-device fee is paid for each one (Rs. 500 per device for MD5 and Rs. 1,000 per device for MD9). However, all devices covered must fall within the same license class — MD5 covers only Class A and B devices, and MD9 covers only Class C and D devices. Manufacturers with a product range spanning both tiers will require separate MD5 and MD9 applications reviewed by different licensing authorities.
Why are aneurysm clips classified as Class D by CDSCO — the highest risk tier?
Aneurysm clips are classified as Class D because they are permanently implanted devices that physically occlude cerebral aneurysms — vascular abnormalities at risk of rupture within or adjacent to the brain. These clips must maintain precise, consistent clamping force over the patient's lifetime, in a location where device failure carries an immediate risk of haemorrhagic stroke and death. The permanence of implantation, proximity to critical neural vasculature, and consequences of failure place aneurysm clips squarely within CDSCO's highest-risk implantable device tier, attracting the full MD9 documentation and manufacturing compliance requirements.
Can an EEG machine be imported under the same MD15 license as an EEG simulator, or do they require separate import licenses?
Each distinct notified neurological device product imported into India requires its own declaration within the MD15 import license. An EEG simulator (Class B) and a complete EEG diagnostic system — if separately notified — would need to be individually listed in the MD15 application. Importers planning to bring multiple neurological device products into India should compile a complete list of all intended products and confirm the notified status and class of each before filing, to ensure the MD15 license is comprehensive and covers the full intended import portfolio from the outset.
Does manufacturing only the lead of a deep brain stimulation system — not the pulse generator — still require an MD9 license?
Yes. The deep brain stimulation system lead is itself a separately classified Class C neurological device under CDSCO's schedule. Manufacturing only the lead — without the pulse generator — still requires an MD9 license from the Central Licensing Authority. Device component manufacturers who supply leads, cables, or connectors to systems integrators should not assume that their component's status as a sub-assembly exempts it from independent licensing. CDSCO's classification operates at the individual device/component level, and each notified component requires its own license if it is manufactured or imported separately.
How does CDSCO's transition of Class C and D neurological devices from registration to licensing affect existing registered device holders?
CDSCO transitioned Class C and D neurological devices from the mandatory registration framework to a licensing structure under GSR 102(E) dated 11 February 2020. Manufacturers and importers who had previously operated under the registration framework were required to obtain the applicable MD9 or MD15 license to continue their activities. Any company that has not yet made this transition — or that is newly entering the market — must obtain the applicable manufacturing or import license before any manufacture or import of notified Class C or D neurological devices can lawfully proceed.
✓ Key Takeaways
- India carries one of the world's largest neurological disease burdens, yet access to specialist care and neurological devices remains structurally constrained — creating a substantial and durable commercial opportunity for CDSCO-licensed manufacturers and importers
- Neurological devices span all four CDSCO risk classes — from tuning forks and TENS systems (Class A/B) to deep brain stimulation leads and CSF shunt programmers (Class C) and spinal cord stimulators, aneurysm clips, and brain-responsive stimulation systems (Class D)
- Three license types apply: MD5 (manufacture Class A/B — State Licensing Authority, Rs. 5,000 + Rs. 500/device), MD9 (manufacture Class C/D — CDSCO Central, Rs. 50,000 + Rs. 1,000/device), and MD15 (import all classes — CDSCO Central)
- All three license types are valid indefinitely — but the retention fee must be paid every 5 years, or the license is automatically cancelled with no grace period
- ISO 13485 certification and a comprehensive Device Master File — with particular emphasis on ISO 14971 risk management and ISO 10993 biocompatibility data for implantable neurological devices — are mandatory for all manufacturing license applications
- The CDSCO application process follows 5 structured steps: document preparation, SUGAM portal submission, query resolution, facility inspection (for manufacturing licenses), and license approval
- First-time manufacturers needing initial batch Certificate of Analysis data will require an MD13 test license before applying for the permanent MD5 or MD9 license
- CDSCO transitioned Class C and D neurological devices from registration to licensing under GSR 102(E) dated 11 February 2020 — all manufacturers and importers must hold the applicable license, not a registration, to operate lawfully
Your Next Step
Neurological medical devices serve some of the most complex and clinically demanding conditions in medicine — conditions that affect millions of people in India who currently have inadequate access to the devices that could improve their diagnosis and quality of life. For device manufacturers and importers entering this segment of the Indian market, securing the correct CDSCO license is both a legal requirement and the foundation on which a compliant, trustworthy, and commercially successful neurological device business is built.
Rego Services' regulatory team brings deep familiarity with CDSCO's requirements across the full neurological device spectrum — from Class A surgical instruments through Class B diagnostic systems, Class C neuromodulation leads and CSF management devices, to Class D implantable spinal cord stimulators, aneurysm clips, and brain-responsive stimulation systems. With our support, the path from device classification through ISO 13485 certification, Device Master File and Plant Master File preparation, SUGAM portal submission, query resolution, and license grant becomes a structured, manageable process rather than the formidable undertaking it can be without specialist regulatory expertise.
Contact Rego Services today to discuss your CDSCO neurological medical device license requirements and receive a device-specific regulatory plan with a realistic timeline for your India market entry.